Frequency of PGP and MRPA efflux pump genes in drug resistance in clinical isolates of Leishmania tropica and L. major

Parishan, Maede; Nateghi, Mahmoud

Frequency of PGP and MRPA efflux pump genes in drug resistance in clinical isolates of Leishmania tropica and L. major

Authors

Maede Parishan ¹

Mahmoud Nateghi ²

¹ Microbial Biotechnology, Payame Noor University of East Tehran, Tehran, Iran

² Qom University of medical science, Health college, Qom, Iran

Abstract

This study aimed to identify PGP and MRPA genes in clinical isolates of Leishmania. The genes of pgpa (MRPA) and mdr1 (PGP) are involved in the drug resistance, their products act as dependent transporters of ATP (ABC Transporter) in the reflux of drugs from the cytosol to the outer space of the cell. Hence, 40 volunteers with leishmaniasis were randomly selected. Firstly, Amastigotes were examined under a light microscope, then inoculated into NNN-specific biphasic culture medium. Deoxy ribonucleic acids were extracted by phenol-chloroform method and were determined by ITS-specific primers. Then the frequency of two pumps involved in "drug resistance" was investigated by PCR. In this study, the mdr1 gene, which had previously been shown to be present in the in vitro resistant strains, was shown to have a higher frequency of pgpas, which could be due to the presence of MDR. It transports the drug from the inner layers of the lipid bilayer membrane to the outer layers, reducing the concentration of the drug inside the cell and causing drug resistance, while the MRPA pump is in the membrane of the cell organelles.

Keywords

ABC transporter

cutaneous leishmaniasis

glucantim

mdr1 gene

pgpa gene

20.1001.1.24236330.1401.9.4.2.4

Ardehali, S., Rezaei, H. & Nadim, A. 1995. Leishmania and Leishmaniasis Parasites. Tehran University Publishing Center 18-24. (In Persian).
Alizadeh, R., Hooshyar, H., Bandehpor, M., Arbadi, M., Kazemi, F., Talari, A. & Kazemi, B. 2011. Detection of drug resistance gene in cutaneous leishmaniasis by PCR in some endemic areas of iran. Iran Red Crescent Medical Journal 13: 863-867.
Beverley, S.M., Coderre, J.A., Schimke, R.T. & Santi, D.V. 1983. Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica. Proceedings of the National Academy of Sciences of the United States 80: 2132-2136.
Croft, S.L., Seifert, K. & Yardley, V. 2006. Current scenario of drug development for leishmaniasis. Indian Journal of Medical Research 123: 399-410.
Callahan, H.L., Beverley, S.M. 1991. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. Journal of Biological Chemistry 266: 18427-18430.
Chow, L.M., Wong, A.K., Ullman, B. & Wirth, D.F. 1993. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Molecular Biochemical Parasitology 60: 195-208.
Chao, C.C., Ma, C.M., Cheng, P.W. & Lin-Chao, S. 1990. Increased mdr gene expression and decreased drug accumulation in a human colonic cancer cell line resistant to hydrophobic drug. Biochemical and Biophysical Research Communications 172: 842-849.
Clifton, M.C., Simon, M.J., Erramilli, S.K., Zhang, H., Zaitseva, J., Hermodson, M.A. & Stauffacher, C.V. 2015. In vitro reassembly of the ribose ATP-binding cassette transporter reveals a distinct set of transport complexes. Journal of Biological Chemistry 290: 5555-5565.
Decuypere, S., Yardley, V., De Doncker, S., Laurent T. & Khanal, B. 2005. Gene expression analysis of the mechanism of natural Sb (v) resistance in Leishmania donovani isolates from Nepal Antimicrobial Agents and Chemotherapy 49: 4616-4621.
Ellenberger, T.E., Beverley, S.M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. Journal of Biological Chemistry 264: 15094-15103.
Ellenberger, T.E., Beverley, S.M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. Journal of Biological Chemistry 264: 15094-15103.
Ferreira-Pinto, K.C., Miranda-Vilela, A.L., Anacleto, C., Fernandes, A.P., Abdo, MC., Petrillo-Peixoto, M.L. & Moreira, E.S. 1996. Leishmania guyanensis: isolation and characterization of glucantim resistance cell lines. Canadian Journal of Microbiology 42: 944-949.
Gokirmak, T., Campanale, J.P., Shipp, L.E., Moy, G.W., Tao, H. & Hamdoun, A. 2012. Localization and substrate selectivity of sea urchin multidrug (MDR) efflux transporters. Journal of Biological Chemistry 287: 43876-43883.
Hadighi, R., Mohebali, M., Boucher, P., Hajjaran, H., Khamesipour, A. & Ouellette, M. 2006. Unresponsiveness to Glucantime treatment in Iranian Cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites. PLOS Medicine 3: 162-168.
Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B.P., Poulin, R. & Ouellette, M. 2011. Elevated levels of polyamines and trypanothione resulting from over expression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Molecular Microbiology 34: 726-735.
Henderson, D.M., Sifri, C.D., Rodgers, M., Wirth, D.F., Hendrickson, N. & Ullman, B. 1992. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene. Molecular and Cellular Biology 12: 2855-2865.
Higgins, C.F. 1992. ABC transporters: from microorganisms to man. Annual Review of Cell Biology 8: 67-113.
Hoffmeyer, S., Arnold, H.P., Brockmoller, J. & Johne, A. 2000. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences 97: 3473-3478.
Juliano, R. L., Ling, V. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta (BBA) – Biomembranes 455: 152-162.
Katakura, K., Iwanami, M., Ohtomo, H., Fujise, H. & Hashiguchi, Y. 1999. Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis. Biochemical and Biophysical Research Communications 255: 289-294.
Legare, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.D., Rosen, B.P. & Haimeur, A. 2001. The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. Journal of Biological Chemistry 276: 26301-26307.
Mohebali, M., Yaghoobi, P., Hooshmand, B. & Khamesipour, A. 2004. Efficacy of Paromomycin ointment prepared in Iran (Paromo-U) against cutaneous Leishmaniasis caused by Leishmania major in mouse model. Iranian Journal of Dermatology 88-94. (In Persian).
Ouellete, M., Fase-Fower, F., Borst, P. 1990. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel p-glycoprotein gene. European Molecular Biology Organization Journal 9: 1027-1033.
Piscopo, T.V. & Mallia, A.C. 2006. Leishmaniasis. Postgraduate Medical Journal 82: 649-657.
Polat, E. & Kutlubay, Z. 2014. Four cutaneous leishmaniosis case resistant to meglumineantimoniate treatment. Turkish Parasitol Derg 38: 177-180.
Sundar, S., More, D.K., Singh, M.K., Singh, V.P., Sharma, S., Makharia, A., Kumar, P.C. & Murray, H.W. 2000. Failure of pentavalent antimony in Visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical Infectious Diseases 31: 1104-1107.
Sundar, S., Chakravarty, J. 2014. An update on pharmacotherapy for leishmaniasis. Expert Opinion on Pharmacotherapy 16: 237-252.
Vincent, I.M. & Barrett, M.P. 2015. Metabolomic-Based Strategies for Anti-Parasite Drug Discovery. Journal of Biomolecular Screening 20: 44-55.